Gene: ZG16B
Official Full Name: zymogen granule protein 16Bprovided by HGNC
Gene Summary: Predicted to enable carbohydrate binding activity. Involved in cell migration. Located in apicolateral plasma membrane; cytoplasm; and extracellular region. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO28117 | ZG16B Knockout cell line (HeLa) | Human | ZG16B | 1:3~1:6 | Negative | Online Inquiry |
KO28118 | ZG16B Knockout cell line (A549) | Human | ZG16B | 1:3~1:4 | Negative | Online Inquiry |
ZG16B Gene Knockout Cell Lines represent a revolutionary advancement in biological research, specifically designed to facilitate the study of gene function associated with the ZG16B gene. This product consists of genetically engineered cell lines in which the ZG16B gene has been completely inactivated, providing researchers a powerful tool for dissecting the molecular pathways and biological processes influenced by this gene. By employing CRISPR/Cas9 technology, these cell lines ensure precise and reliable gene editing, enabling a high degree of specificity in targeting the ZG16B locus.
The primary function of ZG16B Gene Knockout Cell Lines is to allow for the investigation of the gene’s role in various physiological and pathological contexts. Researchers can employ these models to study cellular responses, development processes, metabolic pathways, and disease mechanisms that involve the ZG16B protein. This knockout model is particularly vital in elucidating the gene's involvement in conditions such as immune responses and metabolic disorders, contributing to a more nuanced understanding of its function.
The scientific importance of these cell lines lies in their ability to serve as a reference for comparative studies with wild-type cell lines, providing insights into the biological consequences of ZG16B gene deletion. They are invaluable in drug development, functional genomics, and translational research, offering a customizable platform for therapeutic discovery and validation.
Compared to alternative approaches such as siRNA or shRNA-mediated gene silencing, the ZG16B Gene Knockout Cell Lines offer permanence and reliability in gene exclusion, thereby reducing variability in experimental outcomes. This stability is especially crucial for long-term studies, in contrast to transient knockdown methods which may yield inconsistent results.
For researchers and clinicians, the ZG16B Gene Knockout Cell Lines provide a unique opportunity to explore the intricate gene interactions and pathways that can lead to innovative therapeutic strategies. By eliminating the pitfalls of transient modification techniques, these knockout lines empower scientists to glean deeper insights into gene function, advancing both fundamental science and applied research.
Our company specializes in cutting-edge genetic engineering technologies and is dedicated to providing high-quality biological tools that meet the evolving needs of the scientific community. With our expertise, ZG16B Gene Knockout Cell Lines stand as a testament to our commitment to fostering groundbreaking discoveries in gene function research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.